Literature DB >> 2304480

Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production.

E Hüttner1, U Mergner, R Braun, J Schöneich.   

Abstract

The frequency of 6-thioguanine-resistant peripheral blood lymphocytes has been determined by autoradiography in a control population and a population of cyclophosphamide-exposed individuals. The mean variant frequency in a non-exposed population was found to be 2.76 +/- 1.48 X 10(-5). Subpopulations of smokers and non-smokers revealed statistically significant differences in the variant frequencies, i.e. 3.52 +/- 1.55 X 10(-5) and 2.07 +/- 1.05 X 10(-5) respectively. In 20 out of a total of 23 individuals employed in cyclophosphamide synthesis and manufacturing, the variant frequency of 6-thioguanine-resistant lymphocytes was found to be higher than the maximum individual frequency found in the control population. The mean variant frequency in the cyclophosphamide-exposed population was 13.64 +/- 13.56 X 10(-5), a statistically significant increase as compared to the mean control frequency. There was no correlation between variant frequency and duration of employment suggesting that this test reflects the actual exposure and not a cumulative effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304480     DOI: 10.1016/0165-7992(90)90030-n

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 2.  DNA adducts and mutations in occupational and environmental biomonitoring.

Authors:  K Hemminki
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

3.  Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.

Authors:  L Lennard; J P Hale; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

Review 4.  In vivo mutations in human blood cells: biomarkers for molecular epidemiology.

Authors:  R J Albertini; J A Nicklas; J C Fuscoe; T R Skopek; R F Branda; J P O'Neill
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

5.  The HPRT short-term assay in monitoring individuals exposed to genotoxic agents.

Authors:  R Montero; M E Gonsebatt; L A Herrera; E Rojas; P Ostrosky-Wegman
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

6.  Somatic cell gene mutations in humans: biomarkers for genotoxicity.

Authors:  R J Albertini; J A Nicklas; J P O'Neill
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.